Changing of Dressing for Periprosthetic Joint Infection in Total Knee Arthroplasty

Sponsor
Bezmialem Vakif University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04346875
Collaborator
(none)
842
2
21

Study Details

Study Description

Brief Summary

The primary aim of the study is to compare two methods for a relationship with total knee infection: regular changing of dressings and not changing dressings.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Regularly changing of dressing
  • Procedure: No application
N/A

Detailed Description

Periprosthetic joint infection (PJI) is one of the most dreaded complications that occur after total joint arthroplasty. Periprosthetic joint infection remains an uncommon yet devastating complication that continues to influence the outcome of total joint arthroplasty. (1-4) Although different dressing methods have been described, the effect of changing the frequency of conventional dressings on PJI is curious.

After obtaining informed consent from all participants, parallel-group randomization will be performed with the help of a computer. The first dressing of all participants will be done in the operating room using the same materials. No drains will be used in any patient.

Then, according to the randomization, the procedures will be adjusted by the wound care nurse with the patient. All on-study and outcome data will be collected by the study staff blinded to study group assignment. The dressing group participants will be dressed by the same wound care nurse during the discharge. The dressing group participants will be dressed by the same wound care nurse in an outpatient service every three days using the same material. The total dressing number will be in the dressing group participant 5 times. Both group participants will be evaluated in the outpatient service after 2 weeks. Subsequently, all participants will be invited to check-in at the end of each month. All participants will be evaluated according to MSIS criteria in terms of superficial and deep periprosthetic infection.

The primary endpoint is to detect the difference between the incidence of periprosthetic infection after the regular dressing change and the incidence of the dressing unchanged group. In the secondary endpoint, it is to determine whether dressing change is an independent factor with multiple logistic regression test.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
842 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Single-blindSingle-blind
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Is the Number of Dressing Changes Associated With Acute PJI Following Total Joint Arthroplasty? A Randomized Clinical Trial
Anticipated Study Start Date :
May 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Jan 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Regularly changing group

Participants will undergo dressing every 3 days by the senior wound care nurse

Procedure: Regularly changing of dressing
Conventional dressing

Active Comparator: Non-changing group

Participants will not be subject to dressing change.

Procedure: No application
No dressing change

Outcome Measures

Primary Outcome Measures

  1. Periprosthetic infection rate [90 days]

    Incidence of patients to be diagnosed with periprosthetic infection according to MSIS criteria.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants who agreed to inclusion in the study
Exclusion Criteria:
  • Missing follow-up

  • Participants with insufficient data

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Bezmialem Vakif University

Investigators

  • Principal Investigator: Orkhan Aliyev, MD, Bezmialem Vakif University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Orkhan Aliyev, Residents Doctor in Orthopedics Department, Bezmialem Vakif University
ClinicalTrials.gov Identifier:
NCT04346875
Other Study ID Numbers:
  • 30042020.02
First Posted:
Apr 15, 2020
Last Update Posted:
Apr 15, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2020